We are entering a new era in eHealth. In the coming years, gene-based knowledge, combined with information technology advances, will empower a new kind of medication management: Evidence-based Medicines. We can see over the horizon the delivery of medications that are calibrated to each patient's DNA. The foundation for these changes is our expanding understanding of the human genome and how to target medicines more precisely to each patient, on the basis of individualized genetic factors.
At Mirixa Corporation, we invent and deploy health information technology solutions that integrate pharmacists into the continuum of care. Our clinical and technology teams are hard at work empowering the "triangle of trust:" patient, pharmacist and physician. Our solutions integrate patients into provider-focused health exchange initiatives that access vast amounts of information that will be readily accessible at pharmacies, clinics and hospitals.
Our strategic mission is to enable more robust physician-pharmacist-patient relationships. Patients now have access to easier-to-use, more private communication tools with their care providers. Patients have the opportunity to access broad amounts of relevant information to take more responsibility for their health care decisions and their personalized medication plans. For the first time, patients have access to trusted health content and online tools that enable them to feel more independent, yet connected with their providers.
At Mirixa Corporation, our goal is to generate and change the flow of information exchange between "primary care pharmacists", physicians and patients. Underpinning evidence-based medicine is the confluence of two powerful tools: information technology and knowledge management. These two forces will empower the creation and delivery of individualized medications at an unprecedented level. The full potential of these forces cannot be realized unless electronic systems, clinical databases, and knowledge repositories develop across the health industry.
Of course, health care professionals have always aimed at delivering medications as individualized as possible. But in truth, our ability to deliver the right medicines at the right time for each person has been limited. This is not to say that the progress made by American medicine has been anything but remarkable. But the opportunities that present themselves today hold the possibility over the coming years that are even more far-reaching. They involve not only breakthroughs in scientific knowledge but, equally important, the application of this knowledge on a patient-by-patient basis. Pharmacists will soon serve as the local, trusted distribution point for digital identities that enable personal medications records to reach their full potential.
Drug developers of the future will also see a cheaper, faster, safer system of product discovery. Evidence-based medicine offers the potential of gauging a person's unique drug metabolism. Patients can be tested today to verify if they have a particular combination of thirty possible genetic variations in cytochrome P450, which is responsible for metabolizing approximately forty percent of all medicines. This diagnostic test enables physicians and pharmacists to fine tune medication dosage, based on individual metabolism.
Over the past year, our world-class network of pharmacists stepped up and thousands of patients benefited from drug interaction reviews and enhanced formulary management. In 2007, we are launching additional innovative solutions that further strengthen the patient-physician-pharmacist relationship that lower costs and improve the efficacy of the medications delivered.
The future holds the bright promise that personalized medicine will enable us to live longer and better. Our vision of a new kind of medication management rests on the achievements of the past, the gathering speed of advances in biomedicine and new, superior information technologies. But if the past is a doorway to the future, we can expect the speed of change to be rapid. Converging technology, medication development and product delivery offer new vehicles to drive evidence-based medicine forward.
We're just getting started. Won't you join us help everyone enjoy healthier lives?
